Contrast agents

US7413727B2 · kind B2 · utility

Assignee

• GE HEALTHCARE AS · NO

Inventors

• Jo Klaveness · Oslo, NO
• Anne Naevestad · Oslo, NO
• Helge Tolleshaug · Oslo, NO

Key dates

• Filing date: Jun 17, 2003
• Grant date: Aug 19, 2008
• Expiry date: Jun 17, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K51/1241
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides a composition of matter of the formula (I): V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelias cell receptor, L is a linker moiety or a bond and R is a detectable moiety, characterised in that V is a non-peptidic organic group, or V is peptidic and R is a macromolecular or particulate species providing a multiplicity of labels detectable in in vivo imaging.